$75.57
Insmed is a biotechnology business based in the US. Insmed shares (INSM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $74.54 – a decrease of 0.03% over the previous week. Insmed employs 912 staff and has a trailing 12-month revenue of around $328.6 million.
Our top picks for where to buy Insmed stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Insmed stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – INSM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Insmed stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Insmed stock price (NASDAQ: INSM)
Use our graph to track the performance of INSM stocks over time.Insmed shares at a glance
Latest market close | $74.54 |
---|---|
52-week range | $21.92 - $80.53 |
50-day moving average | $73.81 |
200-day moving average | $48.30 |
Wall St. target price | $88.69 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-5.41 |
Is it a good time to buy Insmed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Insmed price performance over time
Historical closes compared with the close of $74.54 from 2024-10-18
1 week (2024-10-15) | -0.16% |
---|---|
1 month (2024-09-20) | 0.44% |
3 months (2024-07-22) | -2.28% |
6 months (2024-04-22) | 209.17% |
1 year (2023-10-20) | 197.21% |
---|---|
2 years (2022-10-21) | 303.79% |
3 years (2021-10-22) | 171.55% |
5 years (2019-10-22) | 309.11% |
Insmed financials
Revenue TTM | $328.6 million |
---|---|
Gross profit TTM | $190.2 million |
Return on assets TTM | -24.77% |
Return on equity TTM | -1453.41% |
Profit margin | -244.27% |
Book value | $0.23 |
Market Capitalization | $12.8 billion |
TTM: trailing 12 months
Insmed share dividends
We're not expecting Insmed to pay a dividend over the next 12 months.
Have Insmed's shares ever split?
Insmed's shares were split on a 1:10 basis on 2 March 2011 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Insmed shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Insmed shares which in turn could have impacted Insmed's share price.
Insmed share price volatility
Over the last 12 months, Insmed's shares have ranged in value from as little as $21.92 up to $80.53. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insmed's is 1.107. This would suggest that Insmed's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Insmed overview
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. .
Frequently asked questions
nullWhat percentage of Insmed is owned by insiders or institutions?
Currently 0.949% of Insmed shares are held by insiders and 111.413% by institutions. How many people work for Insmed?
Latest data suggests 912 work at Insmed. When does the fiscal year end for Insmed?
Insmed's fiscal year ends in December. Where is Insmed based?
Insmed's address is: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807 What is Insmed's ISIN number?
Insmed's international securities identification number is: US4576693075 What is Insmed's CUSIP number?
Insmed's Committee on Uniform Securities Identification Procedures number is: 457669109
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question